Are higher GGT levels linked to insulin resistance and greater risk of type 2 diabetes?

An evaluation of the relationship between serum gamma-glutamyl transferase (GGT) levels, insulin resistance, and the risk of developing type 2 diabetes reveals strong epidemiological and biological connections.

Clinical and effectiveness evidence

• Predictive Value and Relative Risk: Extensive prospective cohort studies and meta-analyses show a strong, dose-dependent relationship between elevated GGT levels and incident type 2 diabetes. A large meta-analysis of 21 prospective studies demonstrated that a one-unit increase in log-transformed GGT levels corresponds to a hazard ratio (HR) of 1.92 ($95%$ CI, $1.66\text{–}2.21$) for future diabetes.
• Quartile Risk Comparison: Individuals in the highest quartile of GGT exhibit a nearly threefold increased risk of developing type 2 diabetes compared to those in the lowest quartile. This risk gradient remains highly significant even when baseline GGT values are within normal clinical ranges.
• Independence of Association: GGT is a robust predictor of type 2 diabetes independently of classic confounding variables including body mass index (BMI), physical activity, alcohol consumption, and waist circumference. Furthermore, GGT remains a highly significant predictor even after adjusting for other liver enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST).

Mechanistic explanations

• Surrogate of Hepatic Steatosis: GGT serves as a sensitive surrogate marker for ectopic fat accumulation in the liver (hepatic steatosis or NAFLD). Intracellular triglyceride accumulation in hepatocytes induces local tissue inflammation, directly disrupting insulin receptor substrate-1 (IRS-1) signaling, thereby promoting insulin resistance.
• Glutathione Metabolism and Oxidative Stress: GGT is located on the extracellular surface of cell membranes and plays a pivotal role in the degradation of extracellular glutathione, allowing cells to salvage amino acids for intracellular glutathione synthesis. Elevated GGT activity is upregulated in response to chronic oxidative stress and low-grade systemic inflammation, making circulating GGT a direct biomarker of systemic redox imbalance.

Bottom line

Higher GGT levels—even within normal laboratory ranges—are strongly and independently associated with insulin resistance and are a robust, dose-dependent predictor of type 2 diabetes. Clinically, GGT acts as a highly sensitive biomarker of underlying hepatic steatosis, metabolic dysfunction, and cellular oxidative stress.